Navigation Links
FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma'
Date:11/6/2007

Article in Watt Poultry USA states that acidic treatments benefit poultry

processing plants.

SHREVEPORT, La., Nov. 6 /PRNewswire/ -- FreshFx Antimicrobial Solution, which is used to reduce pathogens during poultry processing, was identified in an October 2007 Watt Poultry USA article as helping to solve the "yield/pathogen reduction dilemma."

Citing recent studies in large-scale processing plants, University of Georgia Associate Professor of Poultry Science Scott Russell, Ph.D., stated that adding an acidic disinfectant chemical (such as FreshFx) during scalding "benefits the system, allowing scalder temperatures to be lowered without the concern that Salmonella will begin to grow. And, acids greatly improve picking."

FreshFx is USDA-approved for use anywhere along the processing line: pre-evisceration in the scalder, over picking rails and in the New York rinse; throughout evisceration and for on-line reprocessing (OLR) as rinses or dips; and for pH control in the chillers, as well as post-chill. Since its approval as a processing aid in January 2003, FreshFx has been used to disinfect nearly 2 billion birds.

"FreshFx can maintain antimicrobial activity even in the presence of the accumulated organic load found in scalder water and other immersion systems," said John Dankert, Ph.D., CEO of SteriFx Inc., which manufactures FreshFx. "This contrasts sharply with alternatives that would 'gas-off' at high temperatures or be inhibited by the organic load, reducing effectiveness."

The ability to use lower temperatures for scalding reduces energy costs and decreases the amount of fats and oils that are released, which enhances antimicrobial effectiveness. Also, when less fats and oils are released, an increase in yield not related to moisture might be obtained.

Of course, lower temperatures can also create an environment where Salmonella and other pathogens can thrive, and also lead to less efficient p
'/>"/>

SOURCE SteriFx Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
4. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
5. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
6. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...Africa, Nov. 26 The 2009 Frost &am... in the Generic Pharmaceutical Market is presented...: http://www.newscom.com/cgi-bin/prnh/20081117/FS...e following criteria were used to benchmark Cipla ...th strategy and implementation, degree of innovati...
(Date:11/25/2009)... 25 Heska Corporation ( ... diagnostic and specialty products to the veterina... Diagnostics Corporation for the supply of blood g...erinary market. ,, (Logo: http://www.newsc...ska and Roche share the same passion for innovatin...
(Date:11/25/2009)...25 ERT (Nasdaq: ERES ),... Company,s President and CEO, and Keith Schneck, t... scheduled to present at the 21st Annual Piper Jaf...mber 1, 2009 in New York City, New York. ,, Int...iting the Company,s corporate website at http://w...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Some aspects of birding not always environmentally friendly professor says 9628 1Some aspects of birding not always environmentally friendly professor says 9628 2Some aspects of birding not always environmentally friendly professor says 9628 3Some aspects of birding not always environmentally friendly professor says 9628 4Tobacco Free Kids Welcomes Formation of FDAs Center for Tobacco Products and Selection of Center Director 54902 1Tobacco Free Kids Welcomes Formation of FDAs Center for Tobacco Products and Selection of Center Director 54902 2Veterans Deserve Respect Not Sly Coercion in Advance Care Planning Says Aging with Dignity President 54899 1Veterans Deserve Respect Not Sly Coercion in Advance Care Planning Says Aging with Dignity President 54899 2
...D-Pharm announced,today that the results of the Ph...b99 in the treatment of acute ischemic,stroke pati...erence. The data will be presented by the study,s ...on Thursday May 31st at,14.30 in the Carron Room, ...asgow. The abstract for the presentation may be vi...
...CELSION CORPORATION,(AMEX:CLN) today announced the...using ThermoDox(R), to treat non-resectable liver,...erative Research,and Development Agreement (CRADA)...CI) of the National Institutes of Health, under,th...stigator, Head,Tumor Angiogenesis Section, Surger...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3
(Date:11/27/2009)...7 GSI Group Inc. (Pink S...ion technology products and semiconductor systems,...pany,s shareholders has been scheduled for Friday,...ting will be announced in due course. As previous...otice from Stephen Bershad, a holder of greater th...
(Date:11/27/2009)...PRNewswire-FirstCall/ -- The Gymboree Corporation .../COO, will present at the NASDAQ OMX 23rd Investor... in London, England, on Wednesday, December 2, 200...oadcast of The Gymboree Corporation,s presentation...com, click on "Our Company" at the bottom of the p...
(Date:11/27/2009)...Holdings has announced that it has become a nation... largest nonprofit organizations dedicated to arth... Delray Beach, FL (Vocus) Nove...CHO), a company specializing in the marketing and ...s, has announced today that is has become a nation...
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...wswire/ -- With cold and flu season upon us, it,s ...to control the spread of infections and avoid illn...ep ourselves healthy, but to avoid transmitting il... CIC (certified in infection-control), nursing dir...h at Hospital for Special Surgery (HSS) in Manhatt...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...developed a gel that it says can treat hypogonadis...dism is a condition that causes reduced libido, er...y, and irritability. Like women who grow l... male libido and sexual function, as well as muscl...
...nown for its religious fervour, is emerging as a h...s as Astrology Doctors . Many claim that t... kidney-related problems and others, with their ge...tones are prescribed for patients after studying t...
...as found that diabetes is associated with decrease... developing heart disease . The study, pub...e JAMA/Archives journals, shows that men and women...ut diabetes. Globalization of the Western ...
...search team has identified a gene that, when mutat...rited blindness in babies . Scientists at ...experts from other centres around the world, disco...rs congenital amaurosis (LCA), comes at a time of ...
...iyo Mori said Monday she had confidence in herself...onal Japanese women who are often seen as timid. ... to Japan," Mori, 20, told her first news conferen...Fuji last month became the second Japanese to be c...
...cessfully eased the symptoms of Parkinson's diseas...splants . During the course of study, publ...f Sciences, the scientists isolated stem cells fro...monkeys with a severe form of chemically induced P...
Other Medicine News:Health News:Is Gemstone-therapy an Alternative to Treat Illness? 2Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 3
SureStep Benzodiazepines (BZO 200)
SureStep Propoxyphene (PPX)
SureStep Tricyclic antidepressants (TCA)
THC/COC/MOP/AMPII/MAMPII/BZO200
Medicine Products: